Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference22 articles.
1. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020;17(1):e2–154.
2. Chinitz LA, Melby DP, Marchlinski FE, et al. Safety and efficiency of porous-tip contact-force catheter for drug-refractory symptomatic paroxysmal atrial fibrillation ablation: results from the SMART SF trial. Europace. 2018;20(FI_3):f392-f400.
3. Chen CF, Gao XF, Liu MJ, Jin CL, Xu YZ. Safety and efficacy of the ThermoCool SmartTouch SurroundFlow catheter for atrial fibrillation ablation: a meta-analysis. Clin Cardiol. 2020;43(3):267–74.
4. 21st Century Cures Act, PL 114–255(December 13, 2016).
5. Food and Drug Administration. Use of real-world evidence to support regulatory decision-making for medical devices. https://www.fda.gov/media/99447/download. Published August 31, 2017. Accessed December 19, 2022.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献